Hydroxyzine

Hydroxyzine has been sitting in the pharmacy for sixty years doing useful work, and most prescribers act like it doesn’t exist. It’s an antihistamine in the same H1 family as Benadryl, older and a bit more selective. Decades before anyone marketed it as anything else, doctors noticed that patients on it for hives or for pre-op sedation got noticeably calmer, the FDA eventually gave it a formal anxiety indication, and almost nobody coming out of residency in 2026 acts like they’ve heard of it.

Hydroxyzine has been sitting in the pharmacy for sixty years doing useful work, and most prescribers act like it doesn’t exist.

The reason it matters now is pretty simple. Benzodiazepines (the Xanax/Klonopin/Ativan family, Schedule IV controlled substances that hit your brain’s GABA system to dial down anxiety) cause tolerance and physiologic dependence, kill people in combination with opioids and alcohol, and the regulatory environment for prescribing them long-term has gotten openly hostile, which honestly was overdue. So somebody walks in with situational anxiety, panic spikes, sleep onset that won’t quit, and the prescriber needs something that works PRN… hydroxyzine is sitting right there. No DEA schedule, no abuse liability, no respiratory depression. Onset around thirty minutes, half-life around twenty hours, and it actually works for the body version of anxiety, the chest-tight keyed-up version.

The catch, because there’s always a catch, is that it makes you sleepy. Sometimes pleasantly sleepy, sometimes the kind of sleepy where you shouldn’t drive to your kid’s school. And it’s anticholinergic, which is a fancy word for “dries you out and fogs your thinking a little,” which matters a lot if you’re 78 and already on three other things doing the same thing.

Why most psychiatrists don’t reach for it

Honest answer is laziness plus habit, and I’ll cop to falling into the same trap on bad days. Klonopin works in twenty minutes, the patient feels it work, they thank you on the way out, the visit’s a win. Hydroxyzine works less dramatically, it takes the edge off rather than removing the floor entirely, and patients who’ve been on benzos for a while sometimes try it and report back that it “didn’t do anything,” by which they mean it didn’t feel like a benzo. The somatic load comes down on hydroxyzine, the chest tightness, the racing heart, the can’t-sit-still keyed-up feeling. The chemically-tranquilized cognitive feeling doesn’t show up the same way, which a lot of patients end up preferring once they stop expecting a benzo, because they can take it and still drive their kid to soccer.

The other reason hydroxyzine gets buried is that residency training emphasizes whatever is new and getting marketed. SGAs (second-generation antipsychotics, the Risperdal/Seroquel/Abilify family) for everything, SSRIs and SNRIs for anxiety, gabapentinoids when you’re feeling adventurous. Older drugs get a paragraph in a textbook, hydroxyzine gets half a paragraph and a footnote about Vistaril for itching, and by the time you’re three years out you’ve forgotten the molecule exists unless somebody on your team uses it routinely. Which honestly explains a lot about how prescribing patterns drift.

The kind of guy who really benefits from this drug is the one in his mid-thirties showing up after his last prescriber retired, who’s been on Klonopin twice a day for years, in a forced taper with the new GP who refused to keep writing it. He’s terrified, he’s furious, his anxiety has gone roaring back, and he’s convinced he can’t function without the benzo. Slow the taper down significantly, layer in hydroxyzine 50mg up to four times a day as needed, get an SSRI underneath, and six months later he’s off the Klonopin and takes hydroxyzine maybe twice a week when something flares. The most surprised person in the room is him, and the line he’ll usually say is some version of “I genuinely did not believe an antihistamine was going to do this.” It isn’t an antihistamine in the way the box suggests, but the dismissive read on it is wrong in ways most patients only find out by trying it.

The good uses, the bad fits, the dosing nobody actually gets right

Good for: the chronic keyed-up baseline that is generalized anxiety, anticipatory anxiety before something specific (a flight, a presentation, a funeral), sleep-onset insomnia when anxiety is what’s keeping you awake, itching from anxious skin-picking, and acute agitation in cases where you’re not reaching for a benzo. Reasonable for acute panic if the patient catches it early enough, less reasonable if they’re already in a full panic spiral and want something that works in eight minutes, because hydroxyzine just won’t.

Bad for: anybody who needs immediate-onset relief during a peak episode, anybody already carrying a heavy anticholinergic load (Parkinson’s patients, dementia patients, people on tricyclics, people on bladder anticholinergics), anybody operating heavy machinery or driving for work in the next several hours, and anybody who’s already failed hydroxyzine at a real dose. There’s a real ceiling. Some patients genuinely need a benzo and there’s no clever workaround.

Hydroxyzine isn’t a benzo and isn’t trying to be, and the prescribers who underdose it are the ones who reach for Klonopin instead because the patient asks for it more nicely.

The dosing piece is where prescribers undershoot constantly, including me sometimes. 25mg of hydroxyzine in an adult with real anxiety is basically homeopathic, and the GAD trials that beat placebo (one of them also beating out buspirone) dosed in the 50 to 62.5mg a day range, not the single 25mg a lot of people get handed. The old textbook scheduled dose runs higher, 50mg three or four times a day, which is more than the trials used but reflects how it gets written when somebody needs steady coverage. In practice I start most adults at 25 to 50mg PRN, tell them they can repeat in an hour if they need to, and let them work up to where it actually does something for them. Ceiling is around 400mg/day on paper, I rarely go above 200 in practice.

The anticholinergic problem nobody mentions on the way out of the pharmacy

Hydroxyzine blocks something called muscarinic receptors in addition to the histamine receptor, which is doctor-speak for “dries out a bunch of stuff that you’d rather have a little wet.” That’s where dry mouth, urinary retention (you can’t pee right), blurry near vision, and constipation come from. In a 28-year-old with panic disorder it’s mostly an annoyance, in a 75-year-old with a little memory slippage already, it’s how you end up consulting on a confused grandmother in a hospital bed. The American Geriatrics Society Beers Criteria flags it, and they’re right to. Cumulative anticholinergic burden over years is linked to dementia risk in the observational data, the signal isn’t huge but it’s real, and stacking hydroxyzine onto an oxybutynin onto a tricyclic onto a Benadryl-for-sleep is roughly how you get an older patient who used to be sharp and isn’t anymore.

For older patients I either skip it entirely or cap it hard. 10mg at bedtime for sleep, maybe 25mg PRN with a real plan to reassess in a month, and if they’re already on anything anticholinergic the answer is usually a different drug. Buspirone, low-dose mirtazapine (an old antidepressant that knocks people out at low doses), or just being honest with the family that anxiety in late life is a different animal and trying to medicate it away is usually the move that wrecks things further.

PRN versus scheduled, and how to actually use it

PRN is the default and it’s the easiest sell. Patient has predictable triggers, takes hydroxyzine an hour ahead, gets through the meeting or the flight or the funeral, puts the bottle back in the cabinet. Less useful when anxiety is constant and there’s no clean trigger to time the dose around. For those folks, scheduled 50mg three or four times a day for a few weeks while waiting for an SSRI to do its work is reasonable… the somatic baseline drops, they sleep better at night because they’re less wound up during the day. Once the SSRI is on board you can usually peel the hydroxyzine back to PRN.

One thing I tell every patient on this drug. Hydroxyzine doesn’t build tolerance the way a benzo does. If 50mg worked in March and 50mg isn’t working in November, something else changed. Either the anxiety is worse, or there’s a new stressor, or sleep has fallen apart, or they’re drinking more, or the SSRI underneath stopped doing its job. The dose is almost never the variable that moved, and bumping the dose chasing a tolerance that isn’t actually there is how you end up oversedating somebody.

The thing about meds in general, and this applies here too. If you want it, you get it. I’m a provider, not a parent. My job is the honest take on what’s likely to work and what the trade-offs are, your job is the choice. Some patients hear all of this about hydroxyzine and still want a benzo, and that’s a legitimate conversation we can have… if we’re being honest, sometimes the answer ends up being a small benzo script with clear eyes about what it is and isn’t, written as a fire-extinguisher prescription, not a daily one. I hardly ever say no. The most I’ll do is make it a disapproving yes where you walk out with the script plus a clear sense of what I’d watch for and why I wasn’t thrilled about it.

The piece more prescribers should hear, and I include myself when I’m running behind, is that hydroxyzine sits in a category most of us don’t keep on the mental shortlist. We think in two buckets, daily preventive (SSRIs, SNRIs, buspirone) and rescue (benzodiazepines), and hydroxyzine is a third bucket without its own labeled drawer. Rescue without the schedule, rescue without the dependence, at the price of some sedation and a less dramatic subjective hit. For a real slice of patients that’s exactly the trade they’d take if anybody had offered it, and almost nobody ever does.

Sources

1. Guaiana G, Barbui C, Cipriani A. Hydroxyzine for generalised anxiety disorder. Cochrane Database Syst Rev. 2010;(12):CD006815.pub2. PMID 21154375 (the Cochrane review, which found it beats placebo and runs about even with benzodiazepines and buspirone while warning the underlying studies are too weak to call it a reliable first-line option)
2. Llorca PM, Spadone C, Sol O, et al. Efficacy and safety of hydroxyzine in the treatment of generalized anxiety disorder: a 3-month double-blind study. J Clin Psychiatry. 2002;63(11):1020-1027. PMID 12444816 (the three-month trial that dosed hydroxyzine at 50mg a day against placebo and bromazepam, not against buspirone)
3. Lader M, Scotto JC. A multicentre double-blind comparison of hydroxyzine, buspirone and placebo in patients with generalized anxiety disorder. Psychopharmacology (Berl). 1998;139(4):402-406. PMID 9809861 (the trial where hydroxyzine beat placebo and got compared head to head with buspirone)